Noticias de ARGX_US

Mercado

Noticias del mercado

Últimas noticias sobre ARGX_US — 377 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ARGX_US ✕ 377 resultados
30/09/2026 ARGX_US — Stock Traders Daily
(ARGX) Risk Channels and Responsive Allocation

Price-action only: Argenx Se (ARGX) movements set the tone for institutional models. (ARGX) Risk Channels and Responsive Allocation

30/09/2026 ARGX_US — Stock Traders Daily
(ARGX) Risk Channels and Responsive Allocation

Price-action only: Argenx Se (ARGX) movements set the tone for institutional models. (ARGX) Risk Channels and Responsive Allocation

29/09/2026 ARGX_US — AD HOC NEWS
argenx stock after-hours at EUR 850.90: minus 0.58 percent versus prior close

Las acciones de argenx cotizaban fuera de horario a EUR 850,90 a las 19:02 horas. CEST el 29 de septiembre de 2026, un descenso del 0,58 por ciento

29/09/2026 ARGX_US — Ideal Investisseur
Argenx Presents New Vyvgart Data at AANEM and MGFA Congresses

The immunology group listed on Euronext and Nasdaq announced the presentation of clinical, long-term and real-world data on Vyvgart and candidates from its portfolio at the AANEM and MGFA scientific session congresses, held in Orlando from September 29 to October 2, 2026.<br><br>These presentations cover myasthenia gravis (MG), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) as well as the molecules empasiprubart and adimanebart.

29/09/2026 ARGX_US — Yahoo Finance
argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

New data show deepening improvement in ocular MG and sustained one-year efficacy in anti-AChR antibody-negative MG – broadening VYVGART

29/09/2026 ARGX_US — MarketBeat
argenex (ARGX) FDA Approvals, PDUFA Dates & Drug Alerts 2026

Has argenex received FDA approval? Track FDA approvals, PDUFA dates, and regulatory milestones for ARGX with the latest event history at MarketBeat.

29/09/2026 ARGX_US — Yahoo Finance
argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

New data show deepening improvement in ocular MG and sustained one-year efficacy in anti-AChR antibody-negative MG – broadening VYVGART

29/09/2026 ARGX_US — Yahoo Finance
Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

BOSTON, September 29, 2026--Ginkgo Datapoints and Apheris welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

28/09/2026 ARGX_US — Yahoo Finance
argenx SE (ARGX) Stock Forecasts

En Yahoo Finance, obtienes cotizaciones de acciones gratuitas, noticias actualizadas, recursos de gestión de carteras, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudarán a gestionar tu vida financiera.

28/09/2026 ARGX_US — AD HOC NEWS
argenx stock closes at EUR 844.60 on September 28, 2026, down 0.07 percent

Las acciones de argenx cerraron a 844,60 euros en Euronext Bruselas el 28 de septiembre de 2026, una caída del 0,07 por ciento. Th

28/09/2026 ARGX_US — AD HOC NEWS ES ← EN
Las acciones de argenx informan ahora un crecimiento de ventas del 60 por ciento en el segundo trimestre

Las acciones de argenx registraron 7,32 dólares en el BPA ajustado del segundo trimestre, frente a los 5,86 dólares esperados. MarketBeat citó un dólar de 1,

Página 13 de 19